Advancing a vaccine to prevent hookworm disease and anemia

Vaccine

Volumn 34, Issue 26, 2016, Pages 3001-3005

  Hotez, Peter J ^a,b,c,d   Beaumier, Coreen M ^a,b   Gillespie, Portia M ^a,b   Strych, Ulrich ^a,b   Hayward, Tara ^d   Bottazzi, Maria Elena ^a,b,c,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c BAYLOR UNIVERSITY   (United States)

^d SABIN VACCINE INSTITUTE   (United States)

Author keywords

Hookworm; Necator; Neglected tropical disease; Vaccine

Indexed keywords

HOOKWORM VACCINE; UNCLASSIFIED DRUG; VACCINE;

AFRICAN; ANEMIA; ARTICLE; EUROPEAN; HOOKWORM INFECTION; HUMAN; LOWEST INCOME GROUP; NECATOR AMERICANUS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; VACCINATION; ANIMAL; CLINICAL TRIAL (TOPIC); COMPLICATION; DOG; HOOKWORM INFECTIONS; MEDICAL RESEARCH; PARASITOLOGY; TRENDS;

ANEMIA; ANIMALS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DOGS; HOOKWORM INFECTIONS; HUMANS; NECATOR AMERICANUS; VACCINES;

EID: 84962867398     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.078     Document Type: Article

References (42)

1. Hotez P.J., Brooker S., Bethony J.M., Bottazzi M.E., Loukas A., Xiao S. Hookworm infection. N Engl J Med 2004, 351(8):799-807.
2. Hotez P.J., Alvarado M., Basanez M.G., Bolliger I., Bourne R., Boussinesq M., et al. The Global Burden of Disease Study 2010: implications for the neglected tropical diseases. PLOS Negl Trop Dis 2014, 8(7):e2865.
3. Pullan R.L., Smith J.L., Jasrasaria R., Brooker S.J. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasites Vectors 2014, 7:37.
4. Kassebaum N.J., Jasrasaria R., Naghavi M., Wulf S.K., Johns N., Lozano R., et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014, 123(5):615-624.
5. Brooker S., Hotez P.J., Bundy D.A. Hookworm-related anaemia among pregnant women: a systematic review. PLoS Negl Trop Dis 2008, 2(9):e291.
6. Smith J.L., Brooker S. Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review. Trop Med Int Health 2010, 15(7):776-795.
7. Karagiannis-Voules D.A., Biedermann P., Ekpo U.F., Garba A., Langer E., Mathieu E., et al. Spatial and temporal distribution of soil-transmitted helminth infection in sub-Saharan Africa: a systematic review and geostatistical meta-analysis. Lancet Infect Dis 2015, 15(1):74-84.
8. Sakti H., Nokes C., Hertanto W.S., Hendratno S., Hall A., Bundy D.A., et al. Evidence for an association between hookworm infection and cognitive function in Indonesian school children. Trop Med Int Health 1999, 4(5):322-334.
9. Hotez P. Hookworm and poverty. Ann NY Acad Sci 2008, 1136:38-44.
10. Brooker S., Clements A.C., Hotez P.J., Hay S.I., Tatem A.J., Bundy D.A., et al. The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malar J 2006, 5:99.
11. Albonico M., Bickle Q., Ramsan M., Montresor A., Savioli L., Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ 2003, 81(5):343-352.
12. De Clercq D., Sacko M., Behnke J., Gilbert F., Dorny P., Vercruysse J. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am J Trop Med Hyg 1997, 57(1):25-30.
13. Keiser J., Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. J Am Med Assoc 2008, 299(16):1937-1948.
14. Soukhathammavong P.A., Sayasone S., Phongluxa K., Xayaseng V., Utzinger J., Vounatsou P., et al. Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR. PLoS Negl Trop Dis 2012, 6(1):e1417.
15. Albonico M., Smith P.G., Ercole E., Hall A., Chwaya H.M., Alawi K.S., et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans R Soc Trop Med Hyg 1995, 89(5):538-541.
16. McCarty T.R., Turkeltaub J.A., Hotez P.J. Global progress towards eliminating gastrointestinal helminth infections. Curr Opin Gastroenterol 2014, 30(1):18-24.
17. GBD_Study_2013_Collaborators Global, regional, and national incidence, prevalence, and YLDs, for 301 acute and chronic diseases and injuries for 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study. Lancet 2013, 2015.
18. World Health Organization Sixty-Sixth World Health Assembly, Agenda Item 16.2 2013, Neglected Tropical Diseases.
19. Lee B.Y., Bacon K.M., Bailey R., Wiringa A.E., Smith K.J. The potential economic value of a hookworm vaccine. Vaccine 2011, 29(6):1201-1210.
20. Bethony J., Chen J., Lin S., Xiao S., Zhan B., Li S., et al. Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People's Republic of China. Clin Infect Dis 2002, 35(11):1336-1344.
21. Miller T.A. Transfer of immunity to Ancylostoma caninum infection in pups by serum and lymphoid cells. Immunology 1967, 12(2):231-241.
22. Diemert D.J., Pinto A.G., Freire J., Jariwala A., Santiago H., Hamilton R.G., et al. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol 2012, 130(1):169-176. e6.
23. Hotez P.J., Diemert D., Bacon K.M., Beaumier C., Bethony J.M., Bottazzi M.E., et al. The human hookworm vaccine. Vaccine 2013, 31(Suppl. 2):B227-B232.
24. Hotez P.J., Bethony J.M., Diemert D.J., Pearson M., Loukas A. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 2010, 8(11):814-826.
25. Knox D. Proteases in blood-feeding nematodes and their potential as vaccine candidates. Adv Exp Med Biol 2011, 712:155-176.
26. Loukas A., Bethony J.M., Mendez S., Fujiwara R.T., Goud G.N., Ranjit N., et al. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS Med 2005, 2(10):e295.
27. ClinicalTrials.gov. Safety and Immunogenicity Study of Na-GST-1 With or Without CpG 2015. Available from: [04.06.15]. https://clinicaltrials.gov/ct2/show/NCT02143518?term=necator%26rank=8.
28. ClinicalTrials.gov Safety and immunogenicity of the Na-APR-1 hookworm vaccine in healthy adults 2015, Available from https://clinicaltrials.gov/ct2/show/NCT01717950?term=necator&rank=7 [04.06.15].
29. ClinicalTrials.gov Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults 2015, Available from https://clinicaltrials.gov/ct2/show/NCT02126462?term=necator&rank=10 [04.06.15].
30. ClinicalTrials.gov Experimental infection of hookworm-naïve adults with dermally-applied infectious Necator americanus hookworm larvae 2014, Available from, [23.06.15]. https://clinicaltrials.gov/ct2/show/NCT01940757?term=NCT01940757%26rank=1.
31. ® co-administered with Na-GST-1/Alhydrogel in Brazilian adults 2015, Available from https://clinicaltrials.gov/ct2/show/NCT02476773?term=sabin+necator&rank=5 [23.06.15].
32. ClinicalTrials.gov Safety and immunogenicity of a human hookworm candidate vaccine with different doses of a novel adjuvant 2011, Available from: https://clinicaltrials.gov/ct2/show/NCT01385189?term=hookworm+vaccine&no_unk=Y&rank=8&submit_fld_opt [30.06.15].
33. Curti E., Seid C.A., Hudspeth E., Center L., Rezende W., Pollet J., et al. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate. Hum Vaccines Immunother 2014, 10(7):1914-1925.
34. Goud G.N., Deumic V., Gupta R., Brelsford J., Zhan B., Gillespie P., et al. Expression, purification, and molecular analysis of the Necator americanus glutathione S-transferase 1 (Na-GST-1): a production process developed for a lead candidate recombinant hookworm vaccine antigen. Protein Expr Purif 2012, 83(2):145-151.
35. Seid C.A., Curti E., Jones R.M., Hudspeth E., Rezende W., Pollet J., et al. Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine. Hum Vaccines Immunother 2015, 11:1474-1488.
36. Tang Y.T., Gao X., Rosa B.A., Abubucker S., Hallsworth-Pepin K., Martin J., et al. Genome of the human hookworm Necator americanus. Nat Genet 2014, 46(3):261-269.
37. Policy Cures. G-Finder Available from [updated 16.06.14, 28.07.15]. http://www.policycures.org/.
38. von Philipsborn P., Steinbeis F., Bender M.E., Regmi S., Tinnemann P. Poverty-related and neglected diseases - an economic and epidemiological analysis of poverty relatedness and neglect in research and development. Glob Health Action 2015, 8:25818.
39. Hotez P.J., Van Leeuwen R. HealthAffairs Blog 2015, Available from http://healthaffairs.org/blog/2015/02/19/vaccinating-against-iron-deficiency-anemia-a-new-technology-for-maternal-and-child-health/ [cited 05.08.15].
40. Global Burden of Disease Collaborators Global, regional, and national age-sex specific all-cause and cause-specifi c mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385:117-171.
41. Hotez P.J., Ferris M.T. The antipoverty vaccines. Vaccine 2006, 24(31-32):5787-5799.
42. Hotez P.J., Bethony J., Bottazzi M.E., Brooker S., Buss P. Hookworm: the great infection of mankind. PLoS Med 2005.